Cargando…
Upfront Xpert MTB/RIF testing on various specimen types for presumptive infant TB cases for early and appropriate treatment initiation
BACKGROUND: Diagnosis of tuberculosis (TB) in infants is challenging due to non-specific clinical presentations of the disease in this age-group and low sensitivity of widely available TB diagnostic tools, which in turn delays prompt access to TB treatment. Upfront access to Xpert/MTB RIF (Xpert) te...
Autores principales: | Raizada, Neeraj, Khaparde, Sunil D., Rao, Raghuram, Kalra, Aakshi, Sarin, Sanjay, Salhotra, Virender Singh, Swaminathan, Soumya, Khanna, Ashwani, Chopra, Kamal Kishore, Hanif, M., Singh, Varinder, Umadevi, K. R., Nair, Sreenivas Achuthan, Huddart, Sophie, Tripathi, Rajneesh, Surya Prakash, C. H., Saha, B. K., Denkinger, Claudia M., Boehme, Catharina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116934/ https://www.ncbi.nlm.nih.gov/pubmed/30161142 http://dx.doi.org/10.1371/journal.pone.0202085 |
Ejemplares similares
-
Cost and operational impact of promoting upfront GeneXpert MTB/RIF test referrals for presumptive pediatric tuberculosis patients in India
por: Sarin, Sanjay, et al.
Publicado: (2019) -
Upfront Xpert MTB/RIF for diagnosis of pediatric TB—Does it work? Experience from India
por: Kalra, Aakshi, et al.
Publicado: (2020) -
Scaling-up the Xpert MTB/RIF assay for the detection of tuberculosis and rifampicin resistance in India: An economic analysis
por: Khaparde, Sunil, et al.
Publicado: (2017) -
“Before Xpert I only had my expertise”: A qualitative study on the utilization and effects of Xpert technology among pediatricians in 4 Indian cities
por: McDowell, Andrew, et al.
Publicado: (2018) -
Piloting Upfront Xpert MTB/RIF Testing on Various Specimens under Programmatic Conditions for Diagnosis of TB & DR-TB in Paediatric Population
por: Raizada, Neeraj, et al.
Publicado: (2015)